Lexaria Bioscience Corp (NQ: LEXX )
3.180
+0.030
(+0.95%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
All News about Lexaria Bioscience Corp
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Extensive GLP-1 Study Program
January 16, 2024
Topics
Intellectual Property
Exposures
Intellectual Property
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Extensive GLP-1 Study Program
January 16, 2024
Via CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Lexaria Unveils Extensive Planned 2024 GLP-1 Study Program
January 16, 2024
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://ml.globenewswire.com/media/e37ba76b-1ed6-4de4-b482-a904e4fce250/small/lexaria-jpg.jpg)
GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons
January 10, 2024
![](https://ml.globenewswire.com/media/e37ba76b-1ed6-4de4-b482-a904e4fce250/small/lexaria-jpg.jpg)
Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs
January 08, 2024
TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting New and More Lucrative Global Markets
December 15, 2023
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Lexaria's Investigational New Drug Application Filing Update
December 07, 2023
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.